Form 4: NeuroPace Director Frank M. Fischer Steadily Increases Stake Through Compensation-Based Stock Acquisitions

NeuroPace Inc. Director Frank M. Fischer has consistently increased his direct beneficial ownership of common stock by a total of 23,874 shares across nine transactions from June 2023 to June 2025, primarily through issuances as part of his non-employee director compensation.

Summary

• Frank M. Fischer, a Director at NeuroPace Inc. (NPCE), has reported multiple acquisitions of common stock.
• These acquisitions were made pursuant to the Issuer's non-employee director compensation policy, in lieu of quarterly retainer fees.
• On June 30, 2023, Mr. Fischer acquired 4,469 shares at a price of $4.49 per share, increasing his beneficial ownership to 570,126 shares.
• On September 29, 2023, an additional 2,440 shares were acquired at $9.73 per share, bringing his total to 572,566 shares.
• On December 29, 2023, 2,303 shares were acquired at $10.31 per share, increasing his holdings to 574,869 shares.
• On March 29, 2024, 1,799 shares were acquired at $13.20 per share, resulting in 576,668 shares beneficially owned.
• On June 28, 2024, 3,141 shares were acquired at $7.56 per share, increasing his total to 579,809 shares.
• On September 30, 2024, 3,407 shares were acquired at $6.97 per share, bringing his total to 583,216 shares.
• On December 21, 2024, 2,059 shares were acquired at $11.53 per share, increasing his holdings to 585,275 shares.
• On March 21, 2025, 1,975 shares were acquired at $12.02 per share, resulting in 587,250 shares beneficially owned.
• On June 21, 2025, 2,281 shares were acquired at $10.41 per share, bringing his total beneficial ownership to 589,531 shares.
• In total, Mr. Fischer acquired 23,874 shares of NeuroPace common stock through these compensation-related transactions.

Sentiment

Score: 7

Explanation: The director's beneficial ownership has consistently increased through compensation-based stock issuances, indicating continued alignment with shareholder interests and a long-term commitment to the company.

Positives

• The consistent increase in direct beneficial ownership by a director, even through compensation, indicates continued alignment of management interests with shareholder value.
• The director's stake in the company has grown from 570,126 shares to 589,531 shares over the reported period, demonstrating a long-term commitment.

Future Outlook

The document does not contain explicit forward-looking statements or guidance beyond the scheduled nature of the compensation-based stock issuances.

Industry Context

This Form 4 filing details routine insider transactions for NeuroPace Inc., a company operating in the medical device sector. The acquisition of shares by a non-employee director as part of their compensation policy is a common practice across various industries, including healthcare technology, to align director incentives with long-term company performance.

Related Party Transactions

• The acquisition of shares by Director Frank M. Fischer from NeuroPace Inc. constitutes a related party transaction, as the shares were issued as compensation under the company's non-employee director compensation policy.

Stakeholder Impact

• Shareholders: The increased stock ownership by a director enhances alignment between the director's interests and those of the shareholders, potentially signaling confidence in the company's long-term prospects.
• Employees: No direct impact on employees is mentioned in this filing.
• Customers/Suppliers/Creditors: No direct impact on customers, suppliers, or creditors is mentioned in this filing.

Key Dates

Recommendation

Keywords

NeuroPace, NPCE, Form 4, insider trading, director compensation, stock acquisition, beneficial ownership, Frank M. Fischer, SEC filing